Immunoproteasome deficiency protects in the retina after optic nerve crush

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Schuld, Nathan J ^a   Hussong, Stacy A ^a   Kapphahn, Rebecca J ^a   Lehmann, Ute ^a   Roehrich, Heidi ^a   Rageh, Abrar A ^a   Heuss, Neal D ^a   Bratten, Wendy ^a   Gregerson, Dale S ^a   Ferrington, Deborah A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOPROTEASOME; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE B; SOMATOMEDIN C; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LMP-2 PROTEIN; LMP7 PROTEIN; PSMB10 PROTEIN, MOUSE; PTEN PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; EYE PROTECTION; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OPTIC NERVE INJURY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RETINA; RETINA PIGMENT CELL; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ANIMAL; EPITHELIUM CELL; GENETICS; METABOLISM; NERVE CRUSH; OPTIC NERVE; OXIDATIVE STRESS; PROCEDURES;

MUS;

ANIMALS; CYSTEINE ENDOPEPTIDASES; EPITHELIAL CELLS; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; NERVE CRUSH; NF-KAPPA B; OPTIC NERVE; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RETINA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84929376733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126768     Document Type: Article

References (80)

1. Ferrington DA, Gregerson DS. Immunoproteasomes: Structure, function, and antigen presentation. Prog Mol Biol Transl Sci. 2012;109:75-112. doi: 10.1016/B978-0-12-397863-9.00003-1 [doi]. PMID: 22727420
2. Peters J. Proteasomes: Protein degradation machines of the cell. Trends Biochem Sci. 1994;19:377-382. PMID: 7985232
3. Huber EM, Basler M, Schwab R, Heinemeyer W, Kirk CJ, Groettrup M, et al. Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell. 2012;148:727-738. doi: 10.1016/j.cell.2011.12.030 PMID: 22341445
4. Marques AJ, Palanimurugan R, Matias AC, Ramos PC, Dohmen RJ. Catalytic mechanism and assembly of the proteasome. Chem Rev. 2009;109:1509-1536. doi: 10.1021/cr8004857 PMID: 19265443
5. Dahlmann B, Ruppert T, Kuehn L, Merforth S, Kloetzel P. Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol. 2000;303:643-653. PMID: 11061965
6. Klare N, Seeger M, Janek K, Jungblut PR, Dahlmann B. Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation. J Mol Biol. 2007;373:1-10. PMID: 17804016
7. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78:761-771. PMID: 8087844
8. Goldberg AL, Cascio P, Saric T, Rock KL. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol. 2002;39:147-164. PMID: 12200047
9. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, et al. Neuronal induction of the immunoproteasome in huntington's disease. J Neurosci. 2003;23:11653-11661. 23/37/11653 [pii]. PMID: 14684867
10. Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, et al. Immunoproteasome and LMP2 polymorphism in aged and alzheimer's disease brains. Neurobiol Aging. 2006;27:54-66. PMID: 16298241
11. Ethen CM, Hussong SA, Reilly C, Feng X, Olsen TW, Ferrington DA. Transformation of the proteasome with age-related macular degeneration. FEBS Lett. 2007;581:885-890. PMID: 17289037
12. Ferrington DA, Hussong SA, Roehrich H, Kapphahn RJ, Kavanaugh SM, Heuss ND, et al. Immunoproteasome responds to injury in the retina and brain. J Neurochem. 2008;106:158-169. doi: 10.1111/j. 1471-4159.2008.05345.x PMID: 18346202
13. Paz Gavilan M, Pintado C, Gavilan E, Jimenez S, Rios RM, Vitorica J, et al. Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition. Aging Cell. 2009;8:654-665. doi: 10-1111/j.1474-9726.2009.00519.x PMID: 19747230
14. Jang ER, Lee N, Han S, Wu Y, Sharma LK, Carmony KC, et al. Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway. Molecular BioSystems. 2012;8:2295-2302. PMID: 22722901
15. Maldonado M, Kapphahn RJ, Terluk MR, Heuss ND, Yuan C, Gregerson DS, et al. Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling. PloS one. 2013;8:e56187. doi: 10. 1371/journal.pone.0056187 PMID: 23457524
16. Cai ZP, Shen Z, Van Kaer L, Becker LC. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J. 2008;22:4248-4257. doi: 10.1096/fj.08-105940 [doi]. PMID: 18728217
17. Zu L, Bedja D, Fox-Talbot K, Gabrielson KL, Van Kaer L, Becker LC, et al. Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice. J Mol Cell Cardiol. 2010;49:5-15. doi: 10.1016/j.yjmcc.2010.02.007 PMID: 20153750
18. Homma K, Koriyama Y, Mawatari K, Higuchi Y, Kosaka J, Kato S. Early downregulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury. Neurochem Int. 2007;50:741-748. PMID: 17363111
19. Koriyama Y, Homma K, Sugitani K, Higuchi Y, Matsukawa T, Murayama D, et al. Upregulation of IGF-I in the goldfish retinal ganglion cells during the early stage of optic nerve regeneration. Neurochem Int. 2007;50:749-756. PMID: 17363112
20. Nakazawa T, Shimura M, Tomita H, Akiyama H, Yoshioka Y, Kudou H, et al. Intrinsic activation of PI3K/akt signaling pathway and its neuroprotective effect against retinal injury. Curr Eye Res. 2003;26:55-63. PMID: 12789537
21. Li Y, Schlamp CL, Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci. 1999;40:1004-1008. PMID: 10102300
22. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994;14:4368-4374. PMID: 8027784
23. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786. PMID: 7706025
24. Villegas-Perez M, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ. Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol. 1993;24:23-36. PMID: 8419522
25. Coleman M. Axon degeneration mechanisms: Commonality amid diversity. Nature Reviews Neuroscience. 2005;6:889-898. PMID: 16224497
26. Jane JA, Steward O, Gennarelli T. Axonal degeneration induced by experimental noninvasive minor head injury. J Neurosurg. 1985;62:96-100. PMID: 3964861
27. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science. 2008;322:963-966. doi: 10-1126/science.1161566 [doi]. PMID: 18988856
28. Walker CL, Walker MJ, Liu N, Risberg EC, Gao X, Chen J, et al. Systemic bisperoxovanadium activates akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury. PLoS One. 2012;7:e30012. doi: 10.1371/journal.pone.0030012 PMID: 22253859
29. Van Kaert L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1994;1:533-541. PMID: 7600282
30. Caudill CM, Jayarapu K, Elenich L, Monaco JJ, Colbert RA, Griffin TA. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. J Immunol. 2006;176:4075-4082. 176/7/4075 [pii]. PMID: 16547243
31. Basler M, Moebius J, Elenich L, Groettrup M, Monaco JJ. An altered T cell repertoire in MECL-1-deficient mice. J Immunol. 2006;176:6665-6672. 176/11/6665 [pii]. PMID: 16709825
32. Lehmann U, Heuss ND, McPherson SW, Roehrich H, Gregerson DS. Dendritic cells are early responders to retinal injury. Neurobiol Dis. 2010;40:177-184. doi: 10.1016/j.nbd.2010.05.022 PMID: 20580926
33. Heuss ND, Pierson MJ, Montaniel KR, McPherson SW, Lehmann U, Hussong SA, et al. Retinal dendritic cell recruitment, but not function, was inhibited in MyD88 and TRIF deficient mice. J Neuroinflammation. 2014;11:143-014-0143-1. doi: 10.1186/s12974-014-0143-1 [doi].
34. McPherson SW, Heuss ND, Pierson MJ, Gregerson DS. Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells. J Neuroinflammation. 2014;11:205-014-0205-4. doi: 10.1186/s12974-014-0205-4 [doi].
35. Kapphahn RJ, Giwa BM, Berg KM, Roehrich H, Feng X, Olsen TW, et al. Retinal proteins modified by 4-hydroxynonenal: Identification of molecular targets. Exp Eye Res. 2006;83:165-175. PMID: 16530755
36. Louie JL, Kapphahn RJ, Ferrington DA. Proteasome function and protein oxidation in the aged retina. Exp Eye Res. 2002;75:271-284. PMID: 12384090
37. Ferrington DA, Tran TN, Lew KL, Van Remmen H, Gregerson DS. Different death stimuli evoke apoptosis via multiple pathways in retinal pigment epithelial cells. Exp Eye Res. 2006;83:638-650. PMID: 16682026
38. Kapphahn RJ, Bigelow EJ, Ferrington DA. Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina. Exp Eye Res. 2007;84:646-654. PMID: 17258201
39. Hussong SA, Roehrich H, Kapphahn RJ, Maldonado M, Pardue MT, Ferrington DA. A novel role for the immunoproteasome in retinal function. Invest Ophthalmol Vis Sci. 2011;52:714-723. doi: 10.1167/iovs.10-6032 [doi]. PMID: 20881299
40. Schuld NJ, Hauser AD, Gastonguay AJ, Wilson JM, Lorimer EL, Williams CL. SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers. Cell Cycle. 2014;13:0-1.
41. Schuld NJ, Vervacke JS, Lorimer EL, Simon NC, Hauser AD, Barbieri JT, et al. The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif. J Biol Chem. 2014;289:6862-6876. doi: 10.1074/jbc. M113.527192 [doi]. PMID: 24415755
42. Allcutt D, Berry M, Sievers J. A qualitative comparison of the reactions of retinal ganglion cell axons to optic nerve crush in neonatal and adult mice. Dev Brain Res. 1984;16:231-240.
43. Chen H, Weber AJ. Expression of glial fibrillary acidic protein and glutamine synthetase by müller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor. Glia. 2002;38:115-125. PMID: 11948805
44. Levin LA, Geszvain KM. Expression of ceruloplasmin in the retina: Induction after optic nerve crush. Invest Ophthalmol Vis Sci. 1998;39:157-163. PMID: 9430557
45. Gregerson DS, Lew KL, McPherson SW, Heuss ND, Ferrington DA. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing. Invest Ophthalmol Vis Sci. 2006;47:5385-5394. 47/12/5385 [pii]. PMID: 17122128
46. McPherson SW, Heuss ND, Roehrich H, Gregerson DS. Bystander killing of neurons by cytotoxic T cells specific for a glial antigen. Glia. 2006;53:457-466. PMID: 16355370
47. Cui Q, Yin Y, Benowitz L. The role of macrophages in optic nerve regeneration. Neuroscience. 2009;158:1039-1048. doi: 10.1016/j.neuroscience.2008.07.036 PMID: 18708126
48. Smallwood HS, Loópez-Ferrer D, Squier TC. Aging enhances the production of reactive oxygen species and bactericidal activity in peritoneal macrophages by upregulating classical activation pathways. Biochemistry (N Y). 2011;50:9911-9922.
49. Van den Eynde, Benoît J, Morel S. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr Opin Immunol. 2001;13:147-153. PMID: 11228406
50. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci. 1998;18:8936-8946. PMID: 9786999
51. Frank M, Wolburg H. Cellular reactions at the lesion site after crushing of the rat optic nerve. Glia. 1996;16:227-240. PMID: 8833193
52. Akopian A, Atlasz T, Pan F, Wong S, Zhang Y, Volgyi B, et al. Gap junction-mediated death of retinal neurons is connexin and insult specific: A potential target for neuroprotection. J Neurosci. 2014;34:10582-10591. doi: 10.1523/JNEUROSCI.1912-14.2014 [doi]. PMID: 25100592
53. Misantone LJ, Gershenbaum M, Murray M. Viability of retinal ganglion cells after optic nerve crush in adult rats. J Neurocytol. 1984;13:449-465. PMID: 6481407
54. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E. RGC death in mice after optic nerve crush injury: Oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci. 2000;41:4169-4174. PMID: 11095611
55. Reier P, de Webster H. Regeneration and remyelination of Xenopus tadpole optic nerve fibres following transection or crush. J Neurocytol. 1974;3:591-618. PMID: 4461769
56. Hussong SA, Kapphahn RJ, Phillips SL, Maldonado M, Ferrington DA. Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem. 2010;113:1481-1490. doi: 10.1111/j. 1471-4159.2010.06688.x PMID: 20345760
57. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schröter F, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell. 2010;142:613-624. doi: 10.1016/j. cell.2010.07.036 PMID: 20723761
58. Teoh CY, Davies KJ. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: The 'PrOxI'hypothesis. Arch Biochem Biophys. 2004;423:88-96. PMID: 14871471
59. Ding Q, Dimayuga E, Keller JN. Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxidants & redox signaling. 2006;8:163-172.
60. Vorwerk CK, Zurakowski D, McDermott LM, Mawrin C, Dreyer EB. Effects of axonal injury on ganglion cell survival and glutamate homeostasis. Brain Res Bull. 2004;62:485-490. PMID: 15036562
61. Hirschberg DL, Yoles E, Belkin M, Schwartz M. Inflammation after axonal injury has conflicting consequences for recovery of function: Rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol. 1994;50:9-16. PMID: 8300861
62. Groettrup M, Standera S, Stohwasser R, Kloetzel PM. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci U S A. 1997;94:8970-8975. PMID: 9256419
63. Kotamraju S, Matalon S, Matsunaga T, Shang T, Hickman-Davis J, Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: Potential antioxidative mechanism in endothelial cells. Free Radical Biology and Medicine. 2006;40:1034-1044. PMID: 16540399
64. Ferrer I, Martín B, Castaño JG, Lucas JJ, Moreno D, Olivé M. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. Journal of Neuropathology & Experimental Neurology. 2004;63:484-498.
65. Ostrowska H, Kruszewski K, Kasacka I. Immuno-proteasome subunit LMP7 is up-regulated in the ischemic kidney in an experimental model of renovascular hypertension. Int J Biochem Cell Biol. 2006;38:1778-1785. PMID: 16769238
66. Meiners S, Keller IE, Semren N, Caniard A. Regulation of the proteasome: Evaluating the lung proteasome as a new therapeutic target. Antioxidants & redox signaling. 2014.
67. Kitamura A, Maekawa Y, Uehara H, Izumi K, Kawachi I, Nishizawa M, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest. 2011;121:4150-4160. doi: 10.1172/JCI58414 [doi]. PMID: 21881205
68. Zaiss DM, Bekker CP, Grone A, Lie BA, Sijts AJ. Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. J Immunol. 2011;187:2302-2309. doi: 10. 4049/jimmunol.1101003 [doi]. PMID: 21804012
69. Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kanai Y, Shiozawa T, et al. Molecular approach to uterine leiomyosarcoma: LMP2-deficient mice as an animal model of spontaneous uterine leiomyosarcoma. Sarcoma. 2011;2011:476498. doi: 10.1155/2011/476498 [doi]. PMID: 21437229
70. Schmidt N, Gonzalez E, Visekruna A, Kuhl AA, Loddenkemper C, Mollenkopf H, et al. Targeting the proteasome: Partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut. 2010;59:896-906. doi: 10.1136/gut.2009.203554 [doi]. PMID: 20581238
71. Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, Lauer C, et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med. 2009;15:781-787. doi: 10.1038/nm.1978 PMID: 19525961
72. Wehenkel M, Ban J, Ho Y, Carmony K, Hong J, Kim K. A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice. Br J Cancer. 2012;107:53-62. doi: 10.1038/bjc.2012.243 PMID: 22677907
73. Minghetti L, Ajmone-Cat MA, De Berardinis MA, De Simone R. Microglial activation in chronic neurodegenerative diseases: Roles of apoptotic neurons and chronic stimulation. Brain Res Rev. 2005;48:251-256. PMID: 15850664
74. Hayashi T, Faustman D. NOD mice are defective in proteasome production and activation of NF-kappaB. Mol Cell Biol. 1999;19:8646-8659. PMID: 10567588
75. Christie KJ, Webber CA, Martinez JA, Singh B, Zochodne DW. PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J Neurosci. 2010;30:9306-9315. doi: 10.1523/JNEUROSCI.6271-09.2010 [doi]. PMID: 20610765
76. Leslie NR, Downes CP. PTEN: The down side of PI 3-kinase signalling. Cell Signal. 2002;14:285-295. PMID: 11858936
77. Park KK, Liu K, Hu Y, Kanter JL, He Z. PTEN/mTOR and axon regeneration. Exp Neurol. 2010;223:45-50. doi: 10.1016/j.expneurol.2009.12.032 PMID: 20079353
78. Walker CL, Liu N, Xu X. PTEN/PI3K and MAPK signaling in protection and pathology following CNS injuries. Frontiers in biology. 2013;8:421-433.
79. Ivaska J, Nissinen L, Immonen N, Eriksson JE, Kahari VM, Heino J. Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of akt and glycogen synthase kinase 3 beta. Mol Cell Biol. 2002;22:1352-1359. PMID: 11839802
80. Miller Z, Ao L, Kim KB, Lee W. Inhibitors of the immunoproteasome: Current status and future directions. Curr Pharm Des. 2013;19:4140-4151. CPD-EPUB-20121123-7 [pii]. PMID: 23181576